Mirum Pharmaceuticals (MIRM) Other Gross PP&E Adjustments (2020 - 2025)
Mirum Pharmaceuticals has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$26.0 million for Q4 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$26.0 million for Q4 2025, down 22.68% from a year ago — trailing twelve months through Dec 2025 was -$26.0 million (down 22.68% YoY), and the annual figure for FY2025 was -$26.0 million, down 22.68%.
- Other Gross PP&E Adjustments for Q4 2025 was -$26.0 million at Mirum Pharmaceuticals, down from -$21.4 million in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for MIRM hit a ceiling of -$4.0 million in Q4 2021 and a floor of -$26.0 million in Q4 2025.
- Median Other Gross PP&E Adjustments over the past 5 years was -$9.2 million (2023), compared with a mean of -$12.5 million.
- Biggest five-year swings in Other Gross PP&E Adjustments: grew 1.92% in 2021 and later crashed 167.0% in 2024.
- Mirum Pharmaceuticals' Other Gross PP&E Adjustments stood at -$4.0 million in 2021, then crashed by 68.93% to -$6.8 million in 2022, then plummeted by 35.6% to -$9.2 million in 2023, then plummeted by 130.03% to -$21.2 million in 2024, then decreased by 22.68% to -$26.0 million in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$26.0 million (Q4 2025), -$21.4 million (Q3 2025), and -$23.0 million (Q2 2025) per Business Quant data.